EichorEICHOR
Study identifier: NCT06307652 Synced from ClinicalTrials.gov · August 07, 2026
● Study status: Recruiting

Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function

Condition: Heart Failure and Impaired Kidney Function  ·  Sponsor: AstraZeneca

PhasePhase 3
Planned participants4800
Who can joinAll sexes, 18 Years to 130 Years
Healthy volunteersNo

Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.

About this study

This is a Phase III, international, multi-centre, randomised, double-blind, parallel-group, double-dummy, active-controlled, event-driven study in patients with chronic HF and impaired kidney function who had a recent HF event. The aim is to evaluate the effect of balcinrenone/dapagliflozin vs dapagliflozin, given once daily on top of other classes of SoC, on CV death and HF events.

This description comes directly from the study's public registry record.

Talk to the study team

AstraZeneca Clinical Study Information Center  ·  1-877-240-9479  ·  information.center@astrazeneca.com

Always discuss trial participation with your own doctor first.

Locations (852)

Research SiteAlexander City, Alabama, United StatesRecruiting
Research SiteBirmingham, Alabama, United StatesWithdrawn
Research SiteFairhope, Alabama, United StatesRecruiting
Research SiteHuntsville, Alabama, United StatesRecruiting
Research SitePhoenix, Arizona, United StatesRecruiting
Research SitePhoenix, Arizona, United StatesRecruiting
Research SiteLittle Rock, Arkansas, United StatesRecruiting
Research SiteBeverly Hills, California, United StatesRecruiting
Research SiteCovina, California, United StatesRecruiting
Research SiteEncinitas, California, United StatesTerminated
Research SiteLos Angeles, California, United StatesRecruiting
Research SiteLos Angeles, California, United StatesRecruiting

+ 840 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Look up another condition
Look up another city
Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06307652